Trelegy does not currently have a generic version available. It is a branded medication manufactured by GlaxoSmithKline (GSK) [1].
When might a generic version of Trelegy become available?
The availability of generic Trelegy depends on patent expirations and any potential legal challenges to those patents. Information regarding the specific patent landscape for Trelegy can be found on DrugPatentWatch.com [2].
What is Trelegy used for?
Trelegy is a once-daily single inhaler therapy approved for the maintenance treatment of COPD, asthma, and for the long-term treatment of asthma in adults [1].
What makes up Trelegy?
Trelegy contains three active ingredients: fluticasone furoate, umeclidinium, and vilanterol [1].
How does Trelegy work?
Fluticasone furoate is an inhaled corticosteroid that reduces inflammation in the airways. Umeclidinium is a long-acting muscarinic antagonist (LAMA) that helps to relax and widen the airways. Vilanterol is a long-acting beta2-agonist (LABA) that also helps to open the airways [1].
Who else makes COPD and asthma medications?
Several other pharmaceutical companies manufacture medications for COPD and asthma. These include, but are not limited to, Boehringer Ingelheim, AstraZeneca, and Novartis [3].
What are the potential side effects of Trelegy?
Common side effects of Trelegy include pneumonia, upper respiratory tract infection, and hoarseness [1].
Sources
1. GSK Trelegy Information
2. DrugPatentWatch.com
3. FDA Drug Database